Remove 2020 Remove Contract research organization Remove Life science
article thumbnail

Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

Frost & Sullivan

Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes LabCorp’s drug development business, Covance, with the 2020 Global CRO Company of the Year Award. Contact us: Start the discussion. Contact: Lindsey Whitaker. P: +1 (210) 477-8457. About LabCorp.

article thumbnail

Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome

Frost & Sullivan

Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. We provide services to help life sciences and biopharmaceutical customers everywhere transform scientific discoveries into new treatments.